GB2564515B - Pharmaceutical composition and a method for manufacturing the same - Google Patents
Pharmaceutical composition and a method for manufacturing the same Download PDFInfo
- Publication number
- GB2564515B GB2564515B GB1805951.9A GB201805951A GB2564515B GB 2564515 B GB2564515 B GB 2564515B GB 201805951 A GB201805951 A GB 201805951A GB 2564515 B GB2564515 B GB 2564515B
- Authority
- GB
- United Kingdom
- Prior art keywords
- manufacturing
- same
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1705745.6A GB2561355A (en) | 2017-04-10 | 2017-04-10 | Pharmaceutical composition and a method for manufacturing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB201805951D0 GB201805951D0 (en) | 2018-05-23 |
| GB2564515A GB2564515A (en) | 2019-01-16 |
| GB2564515B true GB2564515B (en) | 2022-10-26 |
Family
ID=58744775
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1705745.6A Withdrawn GB2561355A (en) | 2017-04-10 | 2017-04-10 | Pharmaceutical composition and a method for manufacturing the same |
| GB1805951.9A Active GB2564515B (en) | 2017-04-10 | 2018-04-10 | Pharmaceutical composition and a method for manufacturing the same |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1705745.6A Withdrawn GB2561355A (en) | 2017-04-10 | 2017-04-10 | Pharmaceutical composition and a method for manufacturing the same |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB2561355A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060140989A1 (en) * | 2004-12-22 | 2006-06-29 | Schering Corporation | Pharmaceutical formulations |
| US20080260837A1 (en) * | 2007-04-20 | 2008-10-23 | Qpharma, L.L.C. | Physically stable aqueous suspensions of active pharmaceuticals |
| US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20110015233A1 (en) * | 2009-07-20 | 2011-01-20 | Vetegen, Llc | Stable Pharmaceutical Omeprazole Formulation for Oral Administration |
| WO2013192066A1 (en) * | 2012-06-19 | 2013-12-27 | Intercontinental Great Brands Llc | Chewing gum product and method of production thereof |
| WO2014104412A1 (en) * | 2012-12-28 | 2014-07-03 | Otsuka Pharmaceutical Co., Ltd. | Injectable depot formulation comprising optically active tolvaptan and process of producing the same |
| GB2513172A (en) * | 2013-04-18 | 2014-10-22 | Nupharm Lab Ltd | Liquid dosage form and delivery system |
| US20140364392A1 (en) * | 2013-06-06 | 2014-12-11 | Novartis Ag | Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease |
| CN104523589A (en) * | 2014-12-26 | 2015-04-22 | 万特制药(海南)有限公司 | Oral suspension type medicine composition containing agomelatine |
| WO2017036118A1 (en) * | 2015-08-31 | 2017-03-09 | 诺瑞特国际药业股份有限公司 | Injectable aripiprazole suspension preparation having prolonged shelf life |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4788220A (en) * | 1987-07-08 | 1988-11-29 | American Home Products Corporation (Del.) | Pediatric ibuprofen compositions |
| US8999395B2 (en) * | 2007-02-09 | 2015-04-07 | Ceva Sante Animale | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions |
| BR102012030828A2 (en) * | 2012-12-03 | 2014-09-16 | Ems Sa | PHARMACEUTICAL COMPOSITION UNDERSTANDING DESLORATATIN AND PREDNISOLONE AND THEIR USE |
-
2017
- 2017-04-10 GB GB1705745.6A patent/GB2561355A/en not_active Withdrawn
-
2018
- 2018-04-10 GB GB1805951.9A patent/GB2564515B/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060140989A1 (en) * | 2004-12-22 | 2006-06-29 | Schering Corporation | Pharmaceutical formulations |
| US20080260837A1 (en) * | 2007-04-20 | 2008-10-23 | Qpharma, L.L.C. | Physically stable aqueous suspensions of active pharmaceuticals |
| US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20110015233A1 (en) * | 2009-07-20 | 2011-01-20 | Vetegen, Llc | Stable Pharmaceutical Omeprazole Formulation for Oral Administration |
| WO2013192066A1 (en) * | 2012-06-19 | 2013-12-27 | Intercontinental Great Brands Llc | Chewing gum product and method of production thereof |
| WO2014104412A1 (en) * | 2012-12-28 | 2014-07-03 | Otsuka Pharmaceutical Co., Ltd. | Injectable depot formulation comprising optically active tolvaptan and process of producing the same |
| GB2513172A (en) * | 2013-04-18 | 2014-10-22 | Nupharm Lab Ltd | Liquid dosage form and delivery system |
| US20140364392A1 (en) * | 2013-06-06 | 2014-12-11 | Novartis Ag | Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease |
| CN104523589A (en) * | 2014-12-26 | 2015-04-22 | 万特制药(海南)有限公司 | Oral suspension type medicine composition containing agomelatine |
| WO2017036118A1 (en) * | 2015-08-31 | 2017-03-09 | 诺瑞特国际药业股份有限公司 | Injectable aripiprazole suspension preparation having prolonged shelf life |
Also Published As
| Publication number | Publication date |
|---|---|
| GB201805951D0 (en) | 2018-05-23 |
| GB2561355A (en) | 2018-10-17 |
| GB2564515A (en) | 2019-01-16 |
| GB201705745D0 (en) | 2017-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL323780A (en) | D-homopregnane compounds and a pharmaceutical composition comprising them | |
| IL266454B (en) | Implant and method for forming the implant | |
| PL3559344T3 (en) | Method for manufacturing a packaging material and a packaging material made by the method | |
| SG11202004253QA (en) | Oil-and-fat composition and manufacturing method thereof | |
| ZA201707520B (en) | Bent member and manufacturing method for the same | |
| EP3585511A4 (en) | Metal-molybdate and method for making the same | |
| PL3283551T3 (en) | An activated lignin composition, a method for the manufacturing thereof and use thereof | |
| GB201612960D0 (en) | Pre-treament coating composition and a method for producing the same | |
| PL3231784T3 (en) | A layered tile and a method for manufacturing the layered tile | |
| GB2537977B (en) | A door and a method for manufacturing the same | |
| GB2567619B (en) | Pneumatic device and method for manufacturing the same | |
| EP3263477A4 (en) | Packaging material and method for manufacturing same | |
| PT3802106T (en) | Geocomposite and method for the production thereof | |
| ZA201804964B (en) | Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and method for manufacturing the same | |
| EP3285950A4 (en) | Self brazing material and a method of making the material | |
| ZA202000414B (en) | Clutch and method for the production thereof | |
| EP3424521A4 (en) | Pharmaceutical composition and manufacturing method thereof | |
| PL3484782T3 (en) | Shelf-ready package and method for manufacturing the same | |
| ZA201908090B (en) | Pharmaceutical composition and method for preparing same | |
| EP3244758A4 (en) | Low-fructan grain material and a method for producing the same | |
| PT3665183T (en) | Method of manufacturing a pharmaceutical composition | |
| GB201609412D0 (en) | Self-sanitising compositions and method for the production thereof | |
| GB2540133B (en) | A condiment and a method for making the same | |
| GB2564515B (en) | Pharmaceutical composition and a method for manufacturing the same | |
| HUE061661T2 (en) | Electrode unit and method for manufacturing the same |